Cleerly Receives FDA Breakthrough Device Designation for Heart Disease Risk Staging System
DAIC
MARCH 6, 2024
The CAD Staging System is a noninvasive imaging-based investigational software device that analyzes important and actionable features of coronary atherosclerosis, stenosis and ischemia. Cleerly is committed to accelerating the availability of its technology to healthcare providers and patients alike.
Let's personalize your content